Reduced intensity of early intensification does not increase the risk of relapse in children with standard risk acute lymphoblastic leukemia - a multi-centric clinical study of GD-2008-ALL protocol

Table 3 Prednisone response, bone marrow remission on Day 15 and Day 33

Note: NA not available. M1: < 5% blasts. M2: 5% to ≤25% blasts. M3: > 25% blasts. SR standard risk. IR intermediate risk. HR high risk

ISSN: 1471-2407